Aydemir Duygu, Malik Anjum Naeem, Kulac Ibrahim, Basak Ayse Nazli, Lazoglu Ismail, Ulusu Nuriye Nuray
Department of Medical Biochemistry, School of Medicine, Koc University, Istanbul, Turkey.
Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
Front Bioeng Biotechnol. 2022 Feb 25;10:810243. doi: 10.3389/fbioe.2022.810243. eCollection 2022.
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, and ALS incidence is increasing worldwide. Patients with ALS have respiratory failure at the disease's end stages, leading to death; thus, the lung is one of the most affected organs during disease progression. Tissue stiffness increases in various lung diseases because of impaired extracellular matrix (ECM) homeostasis leading to tissue damage and dysfunction at the end. According to the literature, oxidative stress is the major contributor to ECM dysregulation, and mutant protein accumulation in ALS have been reported as causative to tissue damage and oxidative stress. In this study, we used SOD1 and SOD1 rats and measured lung stiffness of rats by using a custom-built stretcher, where H&E staining is used to evaluate histopathological changes in the lung tissue. Oxidative stress status of lung tissues was assessed by measuring glucose 6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6-PGD), glutathione reductase (GR), glutathione s-transferase (GST), catalase (CAT), and superoxide dismutase 1 (SOD1) levels. Western blot experiments were performed to evaluate the accumulation of the SOD1 mutated protein. As a result, increased lung stiffness, decreased antioxidant status, elevated levels of oxidative stress, impaired mineral and trace element homeostasis, and mutated SOD1 protein accumulation have been found in the mutated rats even at the earlier stages, which can be possible causative of increased lung stiffness and tissue damage in ALS. Since lung damage has altered at the very early stages, possible therapeutic approaches can be used to treat ALS or improve the life quality of patients with ALS.
肌萎缩侧索硬化症(ALS)是最常见的运动神经元疾病,且全球范围内ALS的发病率正在上升。ALS患者在疾病末期会出现呼吸衰竭,进而导致死亡;因此,肺是疾病进展过程中受影响最严重的器官之一。由于细胞外基质(ECM)稳态受损,各种肺部疾病中组织硬度都会增加,最终导致组织损伤和功能障碍。据文献报道,氧化应激是ECM失调的主要原因,并且已报道ALS中突变蛋白的积累是组织损伤和氧化应激的病因。在本研究中,我们使用了SOD1转基因大鼠和SOD1基因突变大鼠,并通过使用定制的担架测量大鼠的肺硬度,其中苏木精-伊红(H&E)染色用于评估肺组织的组织病理学变化。通过测量葡萄糖-6-磷酸脱氢酶(G6PD)、6-磷酸葡萄糖酸脱氢酶(6-PGD)、谷胱甘肽还原酶(GR)、谷胱甘肽S-转移酶(GST)、过氧化氢酶(CAT)和超氧化物歧化酶1(SOD1)水平来评估肺组织的氧化应激状态。进行蛋白质免疫印迹实验以评估SOD1突变蛋白的积累。结果发现,即使在早期阶段,突变大鼠也出现了肺硬度增加、抗氧化状态降低、氧化应激水平升高、矿物质和微量元素稳态受损以及SOD1突变蛋白积累的情况,这些可能是ALS中肺硬度增加和组织损伤的病因。由于肺损伤在很早阶段就已发生改变,因此可以采用可能的治疗方法来治疗ALS或提高ALS患者的生活质量。